FDA grants full approval to Paxlovid to treat COVID-19
May 25, 2023
Paxlovid has been taken by older adults and others at high risk for severe COVID-19 under an emergency use approval.
COVID-19 vaccine patent rules reconsidered by World Trade Organization
Jun 08, 2021
The idea is backed by more than 60 countries, including the United States.
FDA to prioritize full approval for Pfizer COVID-19 vaccine
Jul 16, 2021
Full approval could help boost vaccination efforts in the United States.
European Union passes U.S. in COVID-19 vaccination rates
Aug 09, 2021
Rates of people in the 27-member EU with at least one dose have climbed from less than 4% in mid-February to 60%, whereas rates in the United States rose from nearly 12% to less than 58%.
Most COVID-19-related EUAs not supported by high-quality evidence
Dec 30, 2021
For drugs and vaccines, the emergency use authorizations were mostly supported by randomized clinical trials.
Breakthrough SARS-CoV-2 similar for chronic liver disease with, without cirrhosis
Mar 07, 2023
However, full vaccination was associated with two-thirds lower risk for death with cirrhosis.
J&J says booster shot ups immune response to COVID-19
Aug 25, 2021
The Johnson & Johnson vaccine was not part of the government’s initial booster plan, announced last week. But the company now hopes to be part of the first round of additional shots, which could...
FDA approves drug to help immunocompromised fend off COVID-19
Dec 09, 2021
One dose of Evusheld is administered as two separate, consecutive injections and may be effective for six months.
Prior SARS-CoV-2 infection ups protection for vaccinated
Nov 15, 2021
Prior infection was linked to a lower risk for breakthrough infection among individuals vaccinated with BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna).
FDA approves first breath test for COVID-19
Apr 15, 2022
The test, which must be administered by a trained operator, demonstrates a high degree of accuracy.